Sarcoma News

WAILEA, Hawaii — Patients with CIC-DUX4 rearranged primitive small round blue cell sarcoma represented a separate clinical entity distinct from Ewing sarcoma, according to study results presented at the Connective Tissue Oncology Society Annual Meeting.

WAILEA, Hawaii — Long-term therapy with trabectedin appeared well tolerated among patients with soft tissue sarcoma, according to retrospective study results presented at Connective Tissue Oncology Society Annual Meeting.

Alcohol use — whether light, moderate or heavy — increases cancer risk, and public health measures are needed to reduce high-risk alcohol consumption, according to an ASCO statement.

HemOnc Today and Healio.com/HemOnc will provide live coverage of the Chemotherapy Foundation Symposium, which will be held Nov. 8-10 in New York.

HemOnc Today and Healio.com/HemOnc will provide live coverage of the Connective Tissue Oncology Society Annual Meeting, which will be held Nov. 8-11 in Maui, Hawaii.

Nearly 2 years after former Vice President Joe Biden unveiled the cancer moonshot initiative, The Lancet Oncology Commission has detailed a roadmap to deliver on the recommendations of the moonshot’s blue ribbon panel.

The FDA approved IV rolapitant in combination with other antiemetic agents to prevent delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy for adults.

Oncology leaders who participated in an American Association for Cancer Research webinar this afternoon highlighted several advances in cancer research and emphasized the importance of robust medical research funding.

Sexual orientation of patients with cancer did not appear to influence the distribution of disease sites, according to researchers in the United Kingdom.

NIH launched the Partnership for Accelerating Cancer Therapies, a 5-year public-private research collaboration.